Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

The Role of Low Molecular Weight Heparins in Hepatocellular Carcinoma

This study has been completed.
Information provided by (Responsible Party):
ShenFeng, Eastern Hepatobiliary Surgery Hospital Identifier:
First received: January 21, 2009
Last updated: March 30, 2016
Last verified: March 2016
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: October 2011
  Primary Completion Date: August 2011 (Final data collection date for primary outcome measure)